1. Home
  2. JYNT vs SLDB Comparison

JYNT vs SLDB Comparison

Compare JYNT & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • SLDB
  • Stock Information
  • Founded
  • JYNT 2010
  • SLDB 2013
  • Country
  • JYNT United States
  • SLDB United States
  • Employees
  • JYNT N/A
  • SLDB N/A
  • Industry
  • JYNT Multi-Sector Companies
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • JYNT Miscellaneous
  • SLDB Health Care
  • Exchange
  • JYNT Nasdaq
  • SLDB Nasdaq
  • Market Cap
  • JYNT 154.2M
  • SLDB 124.7M
  • IPO Year
  • JYNT 2014
  • SLDB 2018
  • Fundamental
  • Price
  • JYNT $11.40
  • SLDB $3.26
  • Analyst Decision
  • JYNT Strong Buy
  • SLDB Strong Buy
  • Analyst Count
  • JYNT 2
  • SLDB 12
  • Target Price
  • JYNT $17.50
  • SLDB $17.75
  • AVG Volume (30 Days)
  • JYNT 51.3K
  • SLDB 565.8K
  • Earning Date
  • JYNT 03-13-2025
  • SLDB 03-12-2025
  • Dividend Yield
  • JYNT N/A
  • SLDB N/A
  • EPS Growth
  • JYNT N/A
  • SLDB N/A
  • EPS
  • JYNT N/A
  • SLDB N/A
  • Revenue
  • JYNT $120,795,620.00
  • SLDB N/A
  • Revenue This Year
  • JYNT $3.28
  • SLDB N/A
  • Revenue Next Year
  • JYNT N/A
  • SLDB N/A
  • P/E Ratio
  • JYNT N/A
  • SLDB N/A
  • Revenue Growth
  • JYNT 5.26
  • SLDB N/A
  • 52 Week Low
  • JYNT $9.10
  • SLDB $3.03
  • 52 Week High
  • JYNT $17.82
  • SLDB $15.05
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 62.25
  • SLDB 31.02
  • Support Level
  • JYNT $10.08
  • SLDB $3.03
  • Resistance Level
  • JYNT $11.73
  • SLDB $4.59
  • Average True Range (ATR)
  • JYNT 0.51
  • SLDB 0.32
  • MACD
  • JYNT 0.16
  • SLDB -0.03
  • Stochastic Oscillator
  • JYNT 84.65
  • SLDB 14.74

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: